OpenAlex
PricingAboutJobs
Log inGet started
Work

The Anti‐Parkinson Drug Rasagiline and Its Cholinesterase Inhibitor Derivatives Exert Neuroprotection Unrelated to MAO Inhibition in Cell Culture and in Vivo

HTML

Year: 2001
Type: article
Source: Annals of the New York Academy of Sciences
DOI: 10.1111/j.1749-6632.2001.tb03656.x
Authors: MOUSSA B.H. YOUDIM, A. WADIA, W. TATTON, MARTA WEINSTOCK
Institutions: Technion – Israel Institute of Technology, Icahn School of Medicine at Mount Sinai, Hebrew University of Jerusalem
Language: English

Topic: Cholinesterase and Neurodegenerative Diseases
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: rasagiline, monoamine oxidase B inhibitors, cholinesterase inhibitors, neuroprotection, anti-apoptotic effects, mitochondrial membrane potential, NGF withdrawal, closed head injury, Parkinson's disease, Alzheimer's disease, PC12 cells, neuronal differentiation
SDG: Good health and well-being

Open Access status: closed

Funder: Teva Pharmaceutical Industries
OpenAlex ID: W2091558615
FWCI: 7.588
Cites: 24
Cited by: 148
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security